Profile number 106120

Medische technologie ter ondersteuning van kanker therapie

18/09/2023 Date added

Located in

West-Nederland

Also interesting for this region (s)

  • Noord-Nederland
  • Oost-Nederland
  • Midden-Nederland
  • Zuid-Nederland

General information

Sector

Healthcare

Type of company

Other

Legal entity

Private limited company

Type of transaction

To be determined

Life phase enterprise

Starting

Employees in FTE

< 5

Type of buyer

Investor


Financial information

Turnover last financial year

€ 500.000 - € 1.000.000

Asking price

€ 250.000 - € 1.000.000

Earnings before taxes

€ Loss - € making


Company history/background

Thermotherapie in eerste instantie voor hoofd en halskanker. De therapie versterkt bestaande kankerbehandeling (radio- en chemo therapie). Ook toepasbaar op borstkanker, huidkanker en weke delen kanker. Therapie is ontwikkeld door Erasmus Medisch Centrum.  


Company activities

Bedrijf ontwikkelt de FocusCollar, een machine om tumor(en) in het hoofd en de hals nauwkeurig te verwarmen voor een effectieve behandeling van radio- en chemo therapie. Hierbij maakt ze gebruik van exclusieve patenten van het Erasmus Medisch Centrum. Het EMC is van oudsher het centrum van expertise van dergelijke thermo therapie. Het team en het netwerk bestaat uit experts. Tot 2025 zijn er met name R&D activiteiten.

Ontwikkelfase: prototype in klinische studie met goede resultaten. In 2025 start de verkoop.


Unique selling points
Market
  • 4e pijler kankertherapie (thermo-) naast chemo-, radio- immuno therapie. Gericht op hoofd en hals kanker behandeling. Dat is uniek.
Business model
  • Productontwikkeling tot medio 2025. Dan eerste 8 klantbestellingen bij eerste omzet 2e helft 2025. Directe verkoop en verkoopagenten en distribiteurs. Schaalvergroting met strategische samenwerkingpartners. Unieke behandeltherapie voor hoofd- en hals kanker.

Other
Investment opportunity
  • Momenteel een tussen financieringsronde van € 400 k tot  € 1000 k waarbij al enkele investeerders hebben toegezegd. Er is nog € 250 k nodig minimaal en € 600 k maximaal. De volgende financieringsronde bedraagt € 18 mio waar € 8 mio is toegezegd. Deze ronde vormt een tussenronde om de aanvullende € 10 mio gefinancierd te krijgen.

This profile has been put on-hold by the user. It cannot be responded to at this time.

Medische technologie ter ondersteuning van kanker therapie
Region
West-Nederland
Sector
Healthcare
Type
For sale
Turnover
500.000 - 1.000.000
Overname
250.000 - 1.000.000

This profile has been put on-hold by the user. It cannot be responded to at this time.

Interested or more information?

You can get in touch with the profile provider free of charge and without obligation. After entering your e-mail address you can express your interest or request more information. The data requested by us is intended solely for making contact and will therefore be treated discretely by the receiving party.

This is how you get in touch:

  • Enter your e-mail address below
  • If it is already known, log in or click on forgot password
  • Then fill in the response form and send it
  • We check your response and send it to the provider
  • The provider will contact you within 7 days
  • Didn't hear anything after 7 days? Let us know


Accompanying text for provider

  • Ask your questions
  • Indicate where your interest comes from
  • Tell something about your background

Available capital

Please note: financing a business acquisition requires a minimum of 25% own contribution.


This data is only intended for establishing contact. The data is checked by us before we send it to the provider. Responses that are incomplete or contain incorrect information will not be forwarded.

Postal code

Please enter your postal code and house number and the address will be filled in automatically.


E-mail

Make sure you enter the right data, otherwise the owner cannot contact you.

Phone number

If we contact you, we will always do so confidentially. Please be sure to enter the right number.

Mobile phone number

If we contact you, we will always do so confidentially. Please be sure to enter the right number.


After posting this reaction, an account will be created for you automatically. From here you can easily manage these and any subsequent responses. Create a password below. The password must be at least 6 characters long.